Patients | Sex/ Age(Years old) | Number of electrodes/Side | Hypothetical EZ/Side | Number of RF-TC electrodes | Follow up time after RF-TC(Months) | Frequency of epileptic seizures before RF-TC(times per month) | Frequency of epileptic seizures after RF-TC((times per month) | Reduction rate of seizures | Engel grading after RF-TC(3/6/12/24 months) |
---|---|---|---|---|---|---|---|---|---|
1 | M/32 | 4/R,1/L | MFG/R | 3/R | 59 | 2 | 0 | 100% | I/-/-/- |
2 | F/24 | 5/R | SFG, CG/R | 3/R | 48 | 1 | 1 | 0 | IV/IV/IV/IV |
3 | M/25 | 8/R | MTL/R | 3/R | 49 | 30 | 1 | 96.70% | I/I/II/II |
4 | M/27 | 6/R,2/L | MTL/R | 2/R | 59 | 12 | 4 | 66.70% | II/II/II/III |
5 | M/27 | 5/R,1/L | MFG/R | 3/R | 48 | 8 | 2 | 75% | II/II/II/- |
6 | F/38 | 2/R,8/L | MTL/Bi | 4/L | 52 | 4 | 3 | 25% | IV/IV/IV/IV |
7 | M/14 | 5/R,1/L | MFG/R | 2/R | 49 | 120 | 30 | 75% | II/III/III/- |
8 | M/27 | 5/R,4/L | ITG, Hi/R | 3/R | 57 | 1 | 1 | 0 | IV/IV/IV/IV |
9 | M/24 | 4/R | SFG/R | 2/R | 64 | 4 | 2 | 50% | III/III/-/- |
10 | F/30 | 7/R | MTG, ITG/R | 7/R | 62 | 4 | 0 | 100% | I/I/II/II |
11 | F/26 | 1/R,3/L | MTG, ITG/L | 3/L | 63 | 3 | 2 | 33.30% | III/II/II/- |
12 | F/15 | 9/R,2/L | ITG, Hi/R | 4/R | 56 | 90 | 60 | 33.30% | III/III/III/III |
13 | M/36 | 2/R,5/L | ITG, Hi/L | 3/L | 52 | 15 | 2 | 86.70% | II/II/II/- |
14 | F/33 | 9/R,2/L | MFG/R | 2/R | 57 | 4 | 2 | 50% | II/-/-/- |
15 | M/23 | 8/R,1/L | PL/R | 3/R | 44 | 2 | 1 | 50% | III/III/-/- |
16 | M/44 | 4/R,4/L | MFG/L | 3/L | 46 | 8 | 3 | 62.50% | II/II/II/II |
17 | M/29 | 5/L | IFG, insula, STG/L | 3/L | 54 | 3 | 2 | 33.30% | III/III/III/III |
18 | M/46 | 5/R | MFG/R | 4/R | 50 | 4 | 3 | 25% | III/III/III/III |
19 | F/41 | 4/R,1/L | MTL, insula, TP/R | 4/R | 55 | 5 | 2 | 60% | II/II/II/III |
20 | M/13 | 1/R,3/L | MTL/L | 1/R,3/L | 50 | 1 | 1 | 0 | IV/IV/IV/IV |
21 | F/38 | 5/R | CG/R | 4/R | 47 | 3 | 2 | 33.30% | III/-/-/- |
22 | M/50 | 2/R,2/L | SFG/R | 2/R | 38 | 2 | 0 | 100% | I/-/-/- |
23 | F/48 | 2/R,4/L | MTL/L | 3/L | 40 | 3 | 1 | 66.70% | II/-/-/- |
24 | M/14 | 6/L | SFG, CG/L | 2/L | 37 | 2 | 0 | 100% | I/I/I/I |
25 | M/30 | 2/R,7/L | MTL/L | 3/L | 32 | 2 | 1 | 50% | II/-/-/- |
26 | F/30 | 7/R | SFG/R | 4/R | 39 | 90 | 1 | 98.90% | I/I/I/I |
27 | M/22 | 8/R | MTL/R | 2/R | 37 | 60 | 45 | 25% | III/III/-/- |
28 | M/32 | 5/R,1/L | MTL/R | 3/R | 42 | 2 | 2 | 0 | IV/IV/-/- |
29 | F/38 | 7/L | MTL, TP/L | 3/L | 34 | 90 | 10 | 88.90% | I/I/II/II |
30 | M/22 | 9/R,1/L | MFG/R | 2/R | 34 | 2 | 1 | 50% | III/III/III/III |
31 | M/22 | 8/R | IFG, insula/R | 2/R | 36 | 2 | 3 | 0 | IV/IV/IV/IV |
32 | M/39 | 6/R,1/L | MTL/R | 3/R | 27 | 4 | 0 | 100 | I/I/II/II |
33 | M/27 | 11/L | PL and OL/L | 3/L | 26 | 120 | 20 | 83.30% | II/II/II/II |
34 | F/55 | 5/R,2/L | MTL/R | 2/R | 22 | 6 | 2 | 66.70% | II/III/III/- |
35 | M/17 | 2/R,8/L | SFG, CG/L | 2/L | 23 | 4 | 1 | 75% | II/II/II/- |
36 | M/18 | 2/R,8/L | IFS/L | 3/L | 22 | 30 | 1 | 96.70% | I/I/I/- |
37 | M/12 | 1/R,7/L | CG, OFG/L | 4/L | 24 | 300 | 0 | 100% | I/I/I/I |
38 | M/12 | 1/R,8/L | CG, SFG/L | 5/L | 22 | 30 | 10 | 66.70% | II/III/-/- |
39 | M/39 | 6/R,1/L | CG, OFG/R | 4/R | 20 | 4 | 2 | 50% | II/II/II/- |
40 | M/20 | 10/R | CG, SFG/R | 3/R | 15 | 150 | 2 | 98.70% | I/I/I/- |
41 | M/25 | 10/L | MTL, ITG, TP/L | 4/L | 14 | 2 | 1 | 50% | III/III/III/- |
42 | F/32 | 1/R,11/L | MTL/L | 3/L | 13 | 2 | 1 | 50% | III/III/III/- |
43 | M/31 | 5/R,4/L | MTL/R | 3/R | 13 | 2 | 1 | 50% | III/III/III/- |
44 | F/13 | 10/L | TL and OL/L | 2/L | 9 | 3 | 1 | 66.70% | III/III/-/- |